Sept. 17, 2007--Restore Medical, Inc. (NASDAQ:REST), developer of the innovative Pillar(R) Palatal Implant System - a simple, minimally-invasive treatment to help individuals suffering from snoring and mild-to-moderate obstructive sleep apnea (OSA) - announced enrollment of the first patients in a clinical study evaluating the use of Pillar palatal implants in combination with continuous positive airway pressure (CPAP) therapy in the treatment of mild to moderate OSA... Restore Medical's Press Release -
Blog Archive
-
▼
2007
(16)
-
▼
September
(7)
- Arena Pharmaceuticals, Positive Phase 2 Clinical T...
- Orphan Drug Status to Immtech's Pafuramidine for T...
- Efficacy and Benefit of Restore Medical's Pillar(R...
- Neurogen , Webcast of Insomnia Focus
- Cephalon, PROVIGIL Label Updates
- Restore Medical, Clinical Study to Evaluate Pillar...
- SleePosition, blog about sleep disorders and treat...
-
▼
September
(7)
Thursday, September 20, 2007
Restore Medical, Clinical Study to Evaluate Pillar Palatal Implants in Combination with Continuous Positive Airway Pressure
Libellés :
obstructive sleep apnea,
Restore Medical